NCT03952598 2026-04-14
Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy
National Institutes of Health Clinical Center (CC)
Phase 2 Suspended
Clinical Trials
12 trialsNCT04485559 2026-04-13
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
University of California, San Francisco
Phase 1 Suspended
NCT04309552 2026-01-27
Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma
Weill Medical College of Cornell University
Phase 1 Suspended
NCT06355908 2026-01-20
ENHANCING
Beijing Tiantan Hospital
Phase 1 Suspended
NCT06855628 2025-10-28
Assessment of Novel Metabolic Imaging Modalities as A Predictor Of Therapeutic EfficacyiIn Glioblastoma (GBM)
Stanford University
Phase 2 Suspended
NCT05475522 2025-05-16
SONOFLUO
Sklifosovsky Institute of Emergency Care
Phase NA Suspended
NCT05485038 2025-05-16
GAMMA
Sklifosovsky Institute of Emergency Care
Phase NA Suspended
NCT04222309 2025-04-09
Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)
Northwell Health
Phase 1 Suspended
NCT04209023 2022-09-28
The Use of Navigated Transcranial Magnetic Stimulation (nTMS) in the Inhibition of Neurofunctional Regions of Interest
Neurological Associates of West Los Angeles
Phase NA Suspended
NCT03322813 2022-08-03
ExAblate Blood Brain Barrier Disruption (BBBD) for Planned Surgery in Suspected Infiltrating Glioma
InSightec
Phase NA Suspended
NCT00909558 2010-02-24
Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer
Envita Medical Center, Inc.
Phase 1 Suspended
NCT00003067 2009-02-09
Biological Therapy in Treating Patients With Primary or Advanced Glioma
National Cancer Institute (NCI)
Phase 2 Suspended